Allergy is a Th2-mediated disease that involves the formation of specific IgE antibodies against innocuous environmental substances. The prevalence of allergic diseases has dramatically increased over the past decades, affecting up to 30% of the population in industrialized countries. The understanding of mechanisms underlying allergic diseases as well as those operating in non-allergic healthy responses and allergen-specific immunotherapy has experienced exciting advances over the past 15 years. Studies in healthy non-atopic individuals and several clinical trials of allergen-specific immunotherapy have demonstrated that the induction of a tolerant state in peripheral T cells represent a key step in healthy immune responses to allergens. Both naturally occurring thymus-derived CD4 1 CD25 1 FOXP3 1 Treg and inducible type 1 Treg inhibit the development of allergy via several mechanisms, including suppression of other effector Th1, Th2, Th17 cells; suppression of eosinophils, mast cells and basophils; Ab isotype change from IgE to IgG4; suppression of inflammatory DC; and suppression of inflammatory cell migration to tissues. The identification of the molecules involved in these processes will contribute to the development of more efficient and safer treatment modalities.Key words: Allergy . Allergen-specific immunotherapy . Tolerance . Treg
IntroductionThe immune system is a complex interactive network with the capacity to protect the host from a broad range of pathogens while keeping a state of tolerance to self and innocuous non-self antigens. Immune tolerance-related diseases such as allergy, autoimmunity, tumor tolerance and rejection of organ transplants arise as a direct consequence of dysregulated immune responses. The main clinical manifestations of allergy encompass allergic rhinitis, allergic asthma, food allergy, atopic eczema/ dermatitis and anaphylaxis. Currently, allergen-specific immunotherapy (allergen-SIT) by administration of increasing doses of allergen extracts remains as the single curative treatment of allergic diseases with the potential to modify the course of the disease [1].Adoptive transfer experiments in mouse models of allergy and asthmatic inflammation have shown that Treg are essential for the induction and maintenance of immune tolerance to allergens [2]. In humans, studies on immune responses to allergens in healthy individuals have demonstrated the existence of dominant Treg subsets specific to common environmental allergens [3]. In addition, allergen-SIT represents the only clinically established treatment that induces antigen-specific Treg and peripheral tolerance with the capacity to restore homeostasis in human subjects [3][4][5][6][7][8]. Accordingly, active immune regulation through allergen-specific Treg emerges as a potential therapeutic option
1232Review in the prevention and cure of allergic diseases. The aim of this review is to discuss the immune regulation mechanisms operating in allergic diseases with a focus on the role of Treg in the generation of tolerance agai...
Resistance rates to amikacin, ciprofloxacin, ceftazidime, cefepime, imipenem, cefoperazone/sulbactam and piperacillin/tazobactam in Escherichia coli (n= 438), Klebsiella pneumoniae (n= 444), Pseudomonas aeruginosa (n= 210) and Acinetobacter baumanni (n=200) were determined with e-test in a multicenter surveillance study (Hitit-2) in 2007. ESBL production in Escherichia coli and K. pneumoniae was investigated following the CLSI guidelines. Overall 42.0% of E.coli and 41.4% of K. pneumoniae were ESBL producers. In E. coli , resistance to imipenem was not observed, resistance to ciprofloxacin and amikacin was 58.0% and 5.5% respectively. In K. pneumoniae resistance to imipenem, ciprofloxacin and amikacin was 3.1%, 17.8% 12.4% respectively. In P. aeruginosa the lowest rate of resistance was observed with piperacillin/tazobactam (18.1%). A. baumanni isolates were highly resistant to all the antimicrobial agents, the lowest level of resistance was observed against cefoperazone/sulbactam (52.0%) followed by imipenem (55.5%). this study showed that resistance rates to antimicrobials are high in nosocomial isolates and show variations among the centers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.